This paper attempts to provide some new understanding of the mechanical as well as thermal effects of the Tibetan Plateau (TP) on the circulation and climate in Asia through diagnosis and numerical experiments. The air column over the TP descends in winter and ascends in summer and regulates the surface Asian monsoon flow. Sensible heating on the sloping lateral surfaces appears from the authors’ experiments to be the major driving source. The retarding and deflecting effects of the TP in winter generate an asymmetric dipole zonal-deviation circulation, with a large anticyclone gyre to the north and a cyclonic gyre to the south. Such a dipole deviation circulation enhances the cold outbreaks from the north over East Asia, results in a dry climate in south Asia and a moist climate over the Indochina peninsula and south China, and forms the persistent rainfall in early spring (PRES) in south China. In summer the TP heating generates a cyclonic spiral zonal-deviation circulation in the lower troposphere, which converges toward and rises over the TP. It is shown that because the TP is located east of the Eurasian continent, in summertime the meridional winds and vertical motions forced by the Eurasian continental-scale heating and the TP local heating are in phase over the eastern and central parts of the continent. The monsoon in East Asia and the dry climate in middle Asia are therefore intensified.
Background: Recent studies have shown that bufalin has a good antitumor effect but has high toxicity, poor water solubility, a short half-life, a narrow therapeutic window, and a toxic dose that is close to the therapeutic dose, which all limit its clinical application. This study aimed to determine the targeting efficacy of nanoparticles (NPs) made of methoxy polyethylene glycol (mPEG), polylactic-co-glycolic acid (PLGA), poly-L-lysine (PLL), and cyclic arginineglycine-aspartic acid (cRGD) loaded with bufalin, ie, bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles (BNPs), in SW620 colon cancer-bearing mice. Methods: BNPs showed uniform size. The size, shape, zeta potential, drug loading, encapsulation efficiency, and release of these nanoparticles were studied in vitro. The tumor targeting, cellular uptake, and growth-inhibitory effect of BNPs in vivo were tested. Results: BNPs were of uniform size with an average particle size of 164 ± 84 nm and zeta potential of 2.77 mV. The encapsulation efficiency was 81.7% ± 0.89%, and the drug load was 3.92% ± 0.16%. The results of in vitro cytotoxicity studies showed that although the blank NPs were nontoxic, they enhanced the cytotoxicity of bufalin in BNPs. Drug release experiments showed that the release of the drug was prolonged and sustained. The results of confocal laser scanning microscopy indicated that BNPs could effectively bind to human umbilical vein endothelial cells. In the SW620 xenograft mice model, the BNPs could effectively target the tumor in vivo. The BNPs were significantly more effective than other NPs in preventing tumor growth. Conclusion: BNPs had even size distribution, were stable, and had a slow-releasing and tumortargeting effect. BNPs significantly inhibited colon cancer growth in vitro and in vivo. As a novel drug carrier system, BNPs are a potentially promising targeting treatment for colon cancer.
A novel organic-inorganic composite, sorbic acid intercalated zinc aluminum layered double hydroxides (SA-ZnAl-LDHs) has been successfully assembled by a simple direct coprecipitation method. A holistic approach including normal XRD, FT-IR, and UV-Vis measurements and simultaneous TG/DTA/MS and in situ HT-XRD techniques was employed to explore the supramolecular intercalation structure and the thermal decomposition properties of as-synthesized SA-ZnAl-LDHs material.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.